Literature DB >> 3029048

Isolation and characterization of the complete complementary and genomic DNA sequences of human serum amyloid P component.

S Ohnishi, S Maeda, K Shimada, T Arao.   

Abstract

Complementary and genomic DNA clones corresponding to the human serum amyloid P component (SAP) mRNA have been isolated and analyzed. The nucleotide sequences of the cDNA and the corresponding regions of the genomic SAP DNA reported here were identical, and revealed that after coding for a signal peptide of 19 amino acids and the first two amino acids of the mature SAP protein, there is one small intron of 115-base pairs (bp), followed by a nucleotide sequence coding for the remaining 202 amino acid residues. The SAP gene has an ATATAAA sequence 29-bp upstream from the cap site, but there is no CAAT box-like sequence. A possible polyadenylation signal sequence, ATTAAA, was found to be located 28-bp upstream from the polyadenylation site. A comparison of the genomic SAP DNA sequence with that of human C-reactive protein (CRP) revealed a striking overall homology which was not uniform: several highly conserved regions were bounded by non-homologous regions. This comparison provides further support for the hypothesis that SAP and CRP are products of a gene duplication event.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3029048     DOI: 10.1093/oxfordjournals.jbchem.a121797

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  10 in total

1.  Studies in vivo and in vitro of serum amyloid P component in normals and in a patient with AA amyloidosis.

Authors:  P N Hawkins; G A Tennent; P Woo; M B Pepys
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

2.  Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis.

Authors:  P N Hawkins; R Wootton; M B Pepys
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

3.  Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver.

Authors:  T Toyonaga; O Hino; S Sugai; S Wakasugi; K Abe; M Shichiri; K Yamamura
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

4.  Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure.

Authors:  M B Pepys; T W Rademacher; S Amatayakul-Chantler; P Williams; G E Noble; W L Hutchinson; P N Hawkins; S R Nelson; J R Gallimore; J Herbert
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

5.  Characterization of T-cell tolerance to hepatitis B virus (HBV) antigen in transgenic mice.

Authors:  H Takashima; K Araki; J Miyazaki; K Yamamura; M Kimoto
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

6.  Characterization of the gene encoding mouse serum amyloid P component. Comparison with genes encoding other pentraxins.

Authors:  A S Whitehead; M Rits
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

7.  Fine mapping of the human pentraxin gene region on chromosome 1q23.

Authors:  M T Walsh; A Divane; A S Whitehead
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

8.  Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus.

Authors:  Andrew I Russell; Deborah S Cunninghame Graham; Christopher Shepherd; Cheri A Roberton; John Whittaker; John Meeks; Richard J Powell; David A Isenberg; Mark J Walport; Timothy J Vyse
Journal:  Hum Mol Genet       Date:  2003-11-25       Impact factor: 6.150

9.  A 6000 kb segment of chromosome 1 is conserved in human and mouse.

Authors:  S F Kingsmore; M L Watson; T A Howard; M F Seldin
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

10.  Transgenic mouse expressing a full-length hepatitis C virus cDNA.

Authors:  J Matsuda; M Suzuki; C Nozaki; N Shinya; K Tashiro; K Mizuno; Y Uchinuno; K Yamamura
Journal:  Jpn J Cancer Res       Date:  1998-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.